Research ArticleOriginal Research
GRAPPA Treatment Recommendations: 2021 Update
Laura C. Coates, Nadia Corp, Danielle A. van der Windt, Denis O’Sullivan, Enrique R. Soriano and Arthur Kavanaugh
The Journal of Rheumatology June 2022, 49 (6 Suppl 1) 52-54; DOI: https://doi.org/10.3899/jrheum.211331
Laura C. Coates
1L.C. Coates, MB ChB, PhD, Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, Oxford, UK;
Nadia Corp
2N. Corp, PhD, D.A. van der Windt, PhD, Primary Care Centre Versus Arthritis, School of Medicine, Keele University, Staffordshire, UK;
Danielle A. van der Windt
2N. Corp, PhD, D.A. van der Windt, PhD, Primary Care Centre Versus Arthritis, School of Medicine, Keele University, Staffordshire, UK;
Denis O’Sullivan
3D. O’Sullivan, Our Lady’s Hospice & Care Services, Rheumatic and Musculoskeletal Disease Unit, Dublin, Ireland;
Enrique R. Soriano
4E.R. Soriano, MD, MSc, Rheumatology Unit, Internal Medicine Services and University Institute, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina;
Arthur Kavanaugh
5A. Kavanaugh, MD, Division of Rheumatology Allergy and Immunology, University of California San Diego, La Jolla, California, USA.
References
- 1.↵
- Ritchlin CT,
- Kavanaugh A,
- Gladman DD, et al
- 2.↵
- Coates LC,
- Kavanaugh A,
- Mease PJ, et al
- 3.↵
- Coates LC,
- Corp N,
- van der Windt DA,
- Soriano ER,
- Kavanaugh A
In this issue
The Journal of Rheumatology
Vol. 49, Issue 6 Suppl 1
1 Jun 2022
GRAPPA Treatment Recommendations: 2021 Update
Laura C. Coates, Nadia Corp, Danielle A. van der Windt, Denis O’Sullivan, Enrique R. Soriano, Arthur Kavanaugh
The Journal of Rheumatology Jun 2022, 49 (6 Suppl 1) 52-54; DOI: 10.3899/jrheum.211331